Anzeige
Mehr »
Montag, 25.08.2025 - Börsentäglich über 12.000 News
Mega-Deal in Kanada: Katapultiert sich diese Aktie jetzt in die Top-Liga der Explorer?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von PMLiVE

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
17.06.Roche to advance Parkinson's disease candidate into phase 3 development
17.06.Novartis shares positive late-stage results for Fabhalta in rare blood disorder PNH
17.06.FDA approves new presentation of Celltrion's SteQeyma for paediatric psoriasis
17.06.Bridging the gap: from awareness to action in health equity
16.06.Merck's perioperative Keytruda regimen approved by FDA for head and neck cancer
16.06.AstraZeneca and CSPC Pharmaceuticals enter AI-driven partnership worth $5.3bn
16.06.Moderna's RSV vaccine mRESVIA granted FDA approval to protect younger adults
16.06.Duchenne muscular dystrophy - diagnosis, clinical development and global research
13.06.BioNTech expands mRNA capabilities with $1.25bn CureVac acquisition
13.06.GSK's Blenrep combination recommended by NICE to treat multiple myeloma
13.06.FDA approves tablet formulation of BeOne's targeted cancer drug Brukinsa
13.06.Patient partnerships for life
12.06.FDA approves Nuvation Bio's TKI inhibitor Ibtrozi to treat rare form of lung cancer
12.06.Sanofi/Regeneron share results for Dupixent in atopic dermatitis patients with darker skin tones
12.06.Better together - accelerating innovation and access to rare disease treatments
11.06.UCB's Bimzelx demonstrates lasting efficacy in phase 3 psoriatic arthritis trials
11.06.NewAmsterdam's CETP inhibitor obicetrapib shows promise in Alzheimer's sub-study
11.06.Galderma shares positive two-year results for Nemluvio in atopic dermatitis
11.06.Darwin's dictum on data
10.06.Merck's RSV monoclonal antibody Enflonsia approved by FDA to protect infants
10.06.Alnylam's Amvuttra granted EC approval to treat rare heart disease ATTR-CM
10.06.Sobi/Apellis' pegcetacoplan shows sustained efficacy in phase 3 kidney disease study
10.06.PM Society and the Chartered Institute of Marketing announce partnership
10.06.Shaping the future of cancer care
09.06.The transformative role of AI in the future of healthcare communications